The Role of Immune Mechanisms, Inflammatory Pathways, and Macrophage Activation Syndrome in the Pathogenesis of Hemophagocytic Lymphohistiocytosis

被引:5
|
作者
Bseiso, Omair [1 ]
Zahdeh, Anas [1 ]
Isayed, Obay [2 ]
Mahagna, Seewar [2 ]
Bseiso, Anan [1 ,3 ]
机构
[1] Hebron Univ, Coll Med, Hebron, Palestine
[2] An Najah Natl Univ, Coll Med, Nablus, Palestine
[3] Al Quds Univ, Coll Med, Jerusalem, Palestine
关键词
pathophysiology; macrophage activation syndrome; hlh; hemophagocytic lymphohistiocytosis; hyperinflammatory response; CYTOKINE; DIAGNOSIS; DEFECTS; UPDATE; CELLS;
D O I
10.7759/cureus.33175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review article describes the pathophysiology of hemophagocytic lymphohistiocytosis (HLH). The condition is characterized by excessive stimulation of inflammatory cytokines, lymphocytes, and macrophages, leading to hyperinflammatory disorder with immune dysfunction. The main clinical and diagnostic features include fever >= 38.5 degrees C, splenomegaly, hyperferritinemia, cytopenia, hypofibrinogenemia, hemophagocytosis on the bone marrow, low or absent of natural killer (NK) cell activity, and elevated soluble CD25. Various immunological and inflammatory mechanisms are involved in the pathogenesis of HLH. Moreover, the condition can result in multisystem organ failure, contributing to the high mortality rate in hospital settings.A thorough literature search was conducted by collecting data from multiple articles published on PubMed, Medline, and Google Scholar. The article discusses the cellular and molecular pathways that lead to HLH. Due to the high rate of morbidity and mortality, early diagnosis needs to be established. More research pertaining to molecular biology, immunology, and the genetics of HLH is needed to explore the effective management and treatment of this rare disorder.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Taylor, Maria L.
    Hoyt, Kacie J.
    Han, Joseph
    Benson, Leslie
    Case, Siobhan
    Chandler, Mia T.
    Chang, Margaret H.
    Platt, Craig
    Cohen, Ezra M.
    Day-Lewis, Megan
    Dedeoglu, Fatma
    Gorman, Mark
    Hausmann, Jonathan S.
    Janssen, Erin
    Lee, Pui Y.
    Lo, Jeffrey
    Priebe, Gregory P.
    Lo, Mindy S.
    Meidan, Esra
    Nigrovic, Peter A.
    Roberts, Jordan E.
    Son, Mary Beth F.
    Sundel, Robert P.
    Alfieri, Maria
    Yeun, Jenny Chan
    Shobiye, Damilola M.
    Degar, Barbara
    Chang, Joyce C.
    Halyabar, Olha
    Hazen, Melissa M.
    Henderson, Lauren A.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (09) : 1042 - 1051
  • [22] Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma
    Pascarella, Antonia
    Bracaglia, Claudia
    Caiello, Ivan
    Arduini, Alessia
    Moneta, Gian Marco
    Rossi, Marianna Nicoletta
    Matteo, Valentina
    Pardeo, Manuela
    De Benedetti, Fabrizio
    Prencipe, Giusi
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis
    Weaver, Lehn K.
    Behrens, Edward M.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (05) : 562 - 569
  • [24] Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model
    Liu, David X.
    Pahar, Bapi
    Cooper, Timothy K.
    Perry, Donna L.
    Xu, Huanbin
    Huzella, Louis M.
    Adams, Ricky D.
    Hischak, Amanda M. W.
    Hart, Randy J.
    Bernbaum, Rebecca
    Rivera, Deja
    Anthony, Scott
    St Claire, Marisa
    Byrum, Russell
    Cooper, Kurt
    Reeder, Rebecca
    Kurtz, Jonathan
    Hadley, Kyra
    Wada, Jiro
    Crozier, Ian
    Worwa, Gabriella
    Bennett, Richard S.
    Warren, Travis
    Holbrook, Michael R.
    Schmaljohn, Connie S.
    Hensley, Lisa E.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (04) : 371 - 382
  • [25] Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS): clinical outcome and diagnostics
    La Rosee, Paul
    Schenk, Thomas
    Kunert, Christa
    Hochhaus, Andreas
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (05): : 217 - 225
  • [26] Adult macrophage activation syndrome or reactive hemophagocytic lymphohistiocytosis:: State of the art and perspectives
    Mazodier, K.
    Schleinitz, N.
    Bernit, E.
    Veit, V.
    Jean, R.
    Durand, J. M.
    Harle, J. R.
    Kaplanski, G.
    REVUE DE MEDECINE INTERNE, 2008, 29 : 23 - 27
  • [27] Plasma Exchange, Methylprednisolone, IV Immune Globulin, and Now Anakinra Support Continued PICU Equipoise in Management of Hyperferritinemia-Associated Sepsis/Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Syndrome
    Simon, Dennis W.
    Aneja, Rajesh
    Carcillo, Joseph A.
    Halstead, E. Scott
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (05) : 486 - 488
  • [28] Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome
    Lahiry, Piya
    Naumenko, Sergey
    Couse, Madeline
    Liao, Fangming
    Dominguez, Daniela
    Knight, Andrea
    Levy, Deborah M.
    Misztal, Melissa
    Ng, Lawrence W. K.
    Hiraki, Linda T.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (10) : 1146 - 1151
  • [29] Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation
    Castillo, Leticia
    Carcillo, Joseph
    PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (03) : 387 - 392
  • [30] How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis
    Carcillo, Joseph A.
    Simon, Dennis W.
    Podd, Bradley S.
    PEDIATRIC CRITICAL CARE MEDICINE, 2015, 16 (06) : 598 - 600